Research graph
References from The preventative effects of statin on lung cancer development in patients with idiopathic pulmonary fibrosis using the National Health Insurance Service Database in Korea. Local targets link to admitted publications; unresolved targets remain external evidence.
Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
10.3390/ph15020151 · 2022 · External reference
Beneficial cardiovascular pleiotropic effects of statins
2004 · External reference
Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.
10.1038/nrd1901 · 2005 · External reference
Simvastatin inhibits TGFβ1-induced fibronectin in human airway fibroblasts
10.1186/1465-9921-12-113 · 2011 · External reference
The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle
10.1165/rcmb.2010-0052oc · 2011 · External reference
Do statins improve outcomes for patients with non-small cell lung cancer? A systematic review and meta-analysis protocol
10.1136/bmjopen-2018-022161 · 2018 · External reference
Statins and cancer
10.2174/1871520613666131129105035 · 2014 · External reference
Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor
10.1158/1078-0432.ccr-04-1951 · 2005 · External reference
ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells
10.1016/j.celrep.2021.109880 · 2021 · External reference
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer
10.1002/1878-0261.12816 · 2020 · External reference
The Mevalonate Pathway and Innate Immune Hyper-Responsiveness in the Pathogenesis of COPD and Lung Cancer: Potential for Chemoprevention
10.2174/1874467209666160112130016 · 2017 · External reference
Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer
2021 · External reference
Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines
10.1038/s41598-020-57707-2 · 2020 · External reference
A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
10.1186/s12885-022-09385-8 · 2022 · External reference
Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC
10.1002/cnr2.1368 · 2021 · External reference
Systemic inflammation is associated with inferior disease control and survival in stage III non-small cell lung cancer
10.21037/atm-20-6710 · 2021 · External reference
Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease
10.1371/journal.pone.0140571 · 2015 · External reference
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
10.1136/thoraxjnl-2016-208819 · 2017 · External reference
Statin use reduces decline in lung function: VA Normative Aging Study
10.1164/rccm.200705-656oc · 2007 · External reference
Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study
10.1164/ajrccm.161.1.9906062 · 2000 · External reference
Cumulative incidence of and predictive factors for lung cancer in IPF
10.1111/j.1440-1843.2009.01547.x · 2009 · External reference
Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients
10.1038/s41598-021-87747-1 · 2021 · External reference
Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review
10.1016/j.clon.2022.01.043 · 2022 · External reference
Outcomes of curative-intent radiotherapy in non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD)
10.1016/j.radonc.2021.04.014 · 2021 · External reference
Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases
10.1016/j.jtcvs.2014.08.086 · 2015 · External reference
Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia
10.3892/ol.2012.753 · 2012 · External reference
Cardiovascular events and mortality in a population-based cohort initially diagnosed with ductal carcinoma in situ
10.1186/s12885-021-08494-0 · 2021 · External reference
Effect of Pneumonia on All-cause Mortality after Elderly Hip Fracture: a Korean Nationwide Cohort Study
10.3346/jkms.2020.35.e9 · 2020 · External reference
Incidence and natural course of inflammatory bowel disease in Korea, 2006–2012: a nationwide population-based study
10.1097/mib.0000000000000313 · External reference
E-cigarette-associated Severe Pneumonia in Korea Using Data Linkage between the Korea National Health and Nutrition Examination Survey (KNHANES, 2013–2019) and the National Health Insurance Service (NHIS) Claims Database
10.3346/jkms.2021.36.e331 · 2021 · External reference
Current Status of Korean Alcohol Drinking in Accordance with the Korean Alcohol Guidelines for Moderate Drinking Based on Facial Flushing
10.4082/kjfm.23.0024 · 2023 · External reference
Unresolved reference
2018 · External reference
Recommendations for physical activity in the elderly population: A scoping review of guidelines
10.22540/jfsf-07-018 · 2022 · External reference
Statin use and survival from lung cancer: a population-based cohort study
10.1158/1055-9965.epi-15-0052 · 2015 · External reference
Effects of statin exposure and lung cancer survival: A meta-analysis of observational studies
10.1016/j.phrs.2019.01.016 · 2019 · External reference
Statins use and its impact in EGFR-TKIs resistance to prolong the survival of lung cancer patients: A Cancer registry cohort study in Taiwan
10.1111/cas.14493 · 2020 · External reference
Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation
10.1007/s13277-015-3249-x · 2015 · External reference
Statins improve survival in patients previously treated with nivolumab for advanced non-small cell lung cancer: An observational study
2019 · External reference
Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
10.4143/crt.2016.546 · 2017 · External reference
Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study
10.1186/s12890-019-0905-8 · 2019 · External reference
Idiopathic pulmonary fibrosis and lung cancer: future directions and challenges
10.1183/20734735.0147-2022 · 2022 · External reference
Safety and efficacy of video-assisted versus conventional lung resection for lung cancer
10.1016/j.jtcvs.2008.11.035 · 2009 · External reference
Post-operative acute exacerbation of pulmonary fibrosis in lung cancer patients undergoing lung resection
10.1093/icvts/ivr029 · 2012 · External reference
Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands
10.1093/annonc/mds081 · 2012 · External reference
Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy
10.1186/s13014-019-1221-4 · 2019 · External reference
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment
10.1016/j.esmoop.2022.100404 · 2022 · External reference
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan
10.1183/23120541.00184-2019 · 2020 · External reference
Reduced incidence of lung cancer in patients with idiopathic pulmonary fibrosis treated with pirfenidone
10.1016/j.resinv.2017.09.007 · 2018 · External reference
Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis
10.1159/000486286 · 2018 · External reference
Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury
10.1111/j.1440-1681.2006.04440.x · 2006 · External reference
Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs
10.1164/rccm.200501-041oc · 2005 · External reference
Statin use is associated with improved function and survival of lung allografts
10.1164/rccm.200205-410oc · 2003 · External reference
Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic
10.1016/0092-8674(94)90308-5 · 1994 · External reference
MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas
10.3892/or.2015.3822 · 2015 · External reference
The role of inflammation in lung cancer
10.1007/978-3-0348-0837-8_1 · 2014 · External reference
Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials
10.1371/journal.pone.0077950 · 2013 · External reference
Inflammation and immunity in IPF pathogenesis and treatment
10.1016/j.rmed.2018.12.015 · 2019 · External reference
Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins)
10.1038/sj.bjp.0704173 · 2001 · External reference
TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells
10.1016/j.vph.2006.03.002 · 2006 · External reference
The effect of statin therapy on disease-related outcomes in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
2021 · External reference
Physiological Responses and Prognostic Value of Common Exercise Testing Modalities in Idiopathic Pulmonary Fibrosis
10.1097/hcr.0000000000000362 · 2019 · External reference
Predictors and changes of physical activity in idiopathic pulmonary fibrosis
10.1186/s12890-022-02134-4 · 2022 · External reference
Pulmonary rehabilitation for interstitial lung disease
2021 · External reference
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD: A Propensity-Matched Real-World Study
10.1016/j.chest.2021.10.021 · 2022 · External reference
Lifestyle Behaviors and Clinical Outcomes in Idiopathic Pulmonary Fibrosis
10.1159/000481202 · 2018 · External reference
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
10.1164/rccm.2009-040gl · 2011 · External reference
Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis
10.1164/rccm.201902-0456oc · 2019 · External reference
Pulmonary complications in diabetes mellitus
2014 · External reference
Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer
10.2337/dc09-0880 · 2010 · External reference
Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis
10.1378/chest.123.6.2007 · 2003 · External reference
How does comorbidity influence survival in idiopathic pulmonary fibrosis?
10.1016/j.rmed.2014.01.008 · 2014 · External reference
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021
10.2337/dc21-s009 · 2021 · External reference
Metformin reverses established lung fibrosis in a bleomycin model
10.1038/s41591-018-0087-6 · 2018 · External reference
Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice
10.1016/j.intimp.2014.07.010 · 2014 · External reference
